A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Completed

Plain-English translation of NCT03219216 on ClinicalTrials.gov ↗ · Source last updated March 2020 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(14 sites)

Brazil

Hospital Universitário Cassiano Antônio Moraes - HCUFES /ID# 163512, Vitória, Espírito Santo

Hospital Universitario da Universidade Federal do Maranhao - CEPEC /ID# 163169, São Luís, Maranhão

Universidade Estadual de Maringá /ID# 166436, Maringá, Paraná

Hospital de Clinicas de Porto Alegre /ID# 163166, Porto Alegre, Rio Grande do Sul

Hospital de Clinicas de Porto Alegre /ID# 163167, Porto Alegre, Rio Grande do Sul